Neoprobe Corporation - Financial and Strategic Analysis Review

Summary

Neoprobe Corporation - Financial and Strategic Analysis Review

Neoprobe Corporation (Neoprobe) is a biomedical company. It is principally engaged in developing and commercializing products that enhance critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The product portfolio of Neoprobe includes gamma detection systems, detector probes, accessories, blood flow measurement products including Quantix/OR and Quantix/ND. Pipeline products of the company include Lymphoseek, RIGS and Activated Cellular Therapy. The company is headquartered at Dublin in Ohio, United States

Global Markets Direct's Neoprobe Corporation - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Neoprobe Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • Overview
  • History
  • SWOT Analysis Overview
  • Overview
  • Neoprobe Corporation - Strengths
  • Increased Net Sales
  • Focused Research and Development
  • Strong Hold in Gamma Detection Systems
  • Neoprobe Corporation - Weaknesses
  • Dependence on Third Party Manufacturers
  • Neoprobe Corporation - Opportunities
  • Wireless Laparoscopic Probe
  • Blood Flow Measurement Market
  • Cancer Market
  • Neoprobe Corporation - Threats
  • Intense Competition
  • FDA Regulations
  • Product Liability Claims
  • Impact of Financial Crisis
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Head Office
  • Financial Ratios
  • Capital Market Ratios
  • Annual Ratios
  • Interim Ratios
  • Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Neoprobe Corporation, Key Facts
  • Neoprobe Corporation, Key Ratios
  • Neoprobe Corporation, Share Data
  • Neoprobe Corporation, Key Facts
  • Neoprobe Corporation, History
  • Neoprobe Corporation, Key Employees
  • Neoprobe Corporation, Key Employee Biographies
  • Neoprobe Corporation, Ratios based on current share price
  • Neoprobe Corporation, Annual Ratios
  • Neoprobe Corporation, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Neoprobe Corporation, Performance Chart (2004 - 2008)
  • Neoprobe Corporation, Ratio Charts